Advertisement

Topics

Paul-Ehrlich-Institut Company Profile

13:27 EDT 18th September 2018 | BioPortfolio

The Paul-Ehrlich-Institut was founded on 1st June 1896 as Institut für Serumforschung und Serumprüfung (Institute for Serum Research and Serum Testing) at Steglitz near Berlin as a test and research institution. Its name, which it still bears today, was derived from its first director, Paul Ehrlich. His mission was to develop and implement the basic principles of state control of medicines. This mission was initiated against the background of the strongly fluctuating quality and efficacy of the new therapeutic diphtheria anti-serum developed by Emil von Behring. Thus, the basis for the work done by today’s Paul-Ehrlich-Institut, and the criteria for testing the quality, efficacy and safety of medicines originate from the work by Paul Ehrlich and his co-workers. Paul Ehrlich himself developed the standard for evaluating serum products. This work was especially emphasised by the Nobel Prize committee, when they justified the award of the Nobel Prize for medicine to Paul Ehrlich in 1908.

Location

Paul-Ehrlich-Str. 51-59
Langen
63225
Germany

Contact

Phone: 49 6103 77 0
Fax: 49 6103 77 1234
Email: pei@pei.de


News Articles [363 Associated News Articles listed on BioPortfolio]

Prestigious Paul Ehrlich Award Bestowed Upon Araim Pharmaceuticals Founder, Anthony Cerami

The  Paul Ehrlich and Ludwig Darmstaedter Prize is one of the highest endowed and internationally most distinguished awards in medicine in Germany.  The annual award Read more...

Full or modified clinical programme for biosimilars

Dr Elena Wolff-Holz, from the Paul Ehrlich Institut and Federal Agency for Vaccines and Biomedicines, and Chair of the Biosimilar Medicines Working Party at the European Medicines Agency (EMA), gave a...

Researchers create specialised delivery methods to help treat cancer

More than 100 years ago, German Nobel laureate Paul Ehrlich popularised the "magic bullet" concept -- a method that clinicians might one day use to target invading microbes without harming other parts...

@jeff_cranmer Jeffrey Cranmer

Days after hiring Genentech vet Jason Ehrlich as CMO, ophthalmic company Kodiak Sciences files for NASDAQ #IPO. Ehrlich was lead clinician for Lucentis in diabetic eye disease. @iBonanos takes a look...

Big Data Meets Big Biology in San Diego: Some Takeaways

At the end of the 19th century, the German scientist Paul Ehrlich began to realize that certain chemicals could have highly specific effects on certain diseases. He began to write about the possibilit...

Paul Ehrlich Prize for Anthony Cerami and David Wallach

(Goethe University Frankfurt) Anthony Cerami and David Wallach have -- in their own individual way and independently of one other -- decoded the significance of TNF, helping make the neutralization of...

Researchers show how specialized nucleic acid-based nanostructures could help target cancer cells

More than 100 years ago, German Nobel laureate Paul Ehrlich popularized the "magic bullet" concept -- a method that clinicians might one day use to target invading microbes without harming other parts...

Thermo Scientific Krios Cryo-TEM instrument installed at the Institut Pasteur

(Institut Pasteur) The Institut Pasteur officially unveiled its new Thermo Scientific Krios Cryo-TEM electron microscope at an event in Paris, France, on July 12, 2018. The availability of one of the ...

Drugs and Medications [72 Associated Drugs and Medications listed on BioPortfolio]

3m skin and nasal antiseptic [3M Company ]

3M™ Skin and Nasal Antiseptic(Povidone-Iodine Solution 5% w/w (0.5% available iodine) USP)

3m nexcare cold sore treatment [3M Company ]

Nexcare™ Cold Sore Treatment

3m avagard d [3M Health Care]

Avagard D Instant Hand Antiseptic with Moisturizers

Digiclean slim-line [Ecolab Inc.]

Drug Facts

3m cavilon antifungal [3M Health Care]

Cavilon™Antifungal Cream

PubMed Articles [60 Associated PubMed Articles listed on BioPortfolio]

Paul D. Sturkie: Avian cardiac physiologist.

Sturkie's Avian Physiology is a highly regarded textbook for the study of comparative poultry physiology. Less well known, however, is the contribution of Paul D. Sturkie (1909-2002) as a pioneer in t...

Relevance of a molecular tumour board (MTB) for patients' enrolment in clinical trials: experience of the Institut Curie.

High throughput molecular screening techniques allow the identification of multiple molecular alterations, some of which are actionable and can be targeted by molecularly targeted agents (MTA). We aim...

Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases.

Since Nobel laureate Paul Ehrlich proposed the concept of magic bullet in 1906, Köhler and Milstein discovered Hybridoma technology in 1975, and Greg Winter pioneered the technique to humanize monocl...

Robbing Peter to Pay Paul.

Life Lessons from Paul in the Face of Death.

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

This is a biology driven, monocentric study designed to identify actionable molecular alterations in cancer patients with advanced disease. In this trial, high throughput analysis will be...

Virtual Reality Exercise on the Intensive Care Unit in Heart Patients

This project proposes the development and design of a motor intervention using a cognitive video game and describes the feasibility, safety and acceptability of virtual augmented video gam...

Institut Paoli Calmettes Myelodysplastic Syndromes Database

Database of Institut Paoli-Calmettes patients diagnosed with Myelodysplastic Syndromes

Thyroid Cosmesis Study at St. Paul's Hospital, Vancouver BC

This study looks at the difference in surgical scar outcomes between two different surgical incision methods during thyroid surgery: scalpel vs electrocautery. Patients who are already sch...

Impact of Patient Education Website on the Quality of Outpatient Bowel Preparation for Colonoscopy

The purpose of this study is to evaluate the effectiveness of the GI clinic's currently used web-based instructions at St. Paul's Hospital.

Companies [164 Associated Companies listed on BioPortfolio]

Paul-Ehrlich-Institut

The Paul-Ehrlich-Institut was founded on 1st June 1896 as Institut für Serumforschung und Serumprüfung (Institute for Serum Research and Serum Testing) at Steglitz near Berlin as a test and research...

Statens Serum Institut

Statens Serum Institut is a public enterprise operating as a market-oriented production and service enterprise.Statens Serum Institut is an enterprise under the Danish Ministry of the Interior and Hea...

Institut Pasteur

The Institut Pasteur is a non-profit foundation dedicated to the prevation and treatment of diseases through biological research,education and public health activites

Ehrlich

institut merieux

With extensive experience in industrial microbiology, Institut Merieux contributes to serving medicine and public health across the globe. For the fight against infectious diseases and cancer, it ...

More Information about "Paul-Ehrlich-Institut" on BioPortfolio

We have published hundreds of Paul-Ehrlich-Institut news stories on BioPortfolio along with dozens of Paul-Ehrlich-Institut Clinical Trials and PubMed Articles about Paul-Ehrlich-Institut for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Paul-Ehrlich-Institut Companies in our database. You can also find out about relevant Paul-Ehrlich-Institut Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record